MUMBAI, Feb 9, 2026, 19:26 IST
- Roughly 170 firms are on the docket to release their October-December results Monday—names on the list include BSE, Zydus Lifesciences, Aurobindo Pharma, and Bata India.
- Over 1,600 companies are set to report their December-quarter numbers this week. Titan, Mahindra & Mahindra, Hindustan Unilever, ONGC, Coal India, and HAL are some of the more prominent ones on the docket.
- Brokerages keep an eye on demand signals and margin pressure—watching everything from gold price moves affecting jewelry sales to how state-run producers react to shifts in oil prices.
Roughly 170 Indian firms are slated to post quarterly numbers on Monday, covering the period ending Dec. 31, 2025. The batch includes BSE Ltd, Zydus Lifesciences, Aurobindo Pharma, and Bata India. Motilal Oswal projects a 20.9% year-on-year jump in revenue for Zydus. For Aurobindo, Kotak Institutional Equities is looking for U.S. sales (excluding generic Revlimid) to climb 4% from the previous quarter.
Indian equities advanced Monday, with the Nifty 50 climbing 0.68% and the Sensex gaining 0.58%, buoyed by hopes around a trade deal and stronger-than-expected results from State Bank of India. “The interim trade framework is a sentimental positive for markets,” said Dharmesh Kant, head of equity research at Cholamandalam Securities. IIFL Capital noted, “Earnings downgrades are moderating and upgrades should begin soon.” Reuters
The earnings deluge grinds on into week five, with about 1,600 firms set to unveil their December-quarter results shortly. “The earnings calendar stays active,” Religare Broking’s Ajit Mishra commented. Kotak is looking for Mahindra & Mahindra revenue growth of around 30% year-on-year. Over at Motilal Oswal, analysts flagged downside for ONGC, citing Krishna-Godavari basin project delays and oil prices dipping under $60 a barrel. mint
Hindustan Unilever is set to release its results on Feb. 12, with an earnings call slated for 4 p.m. local time. Mahindra & Mahindra lines up its own call for Feb. 11, running from 3:30 p.m. to 4:30 p.m., according to NDTV Profit. Also reporting that day: Coal India, ONGC, Hindustan Aeronautics, plus a few others.
On the earnings docket a day before, Titan, Eicher Motors, Britannia Industries, Grasim Industries, plus Apollo Hospitals and Oil India are all slated to post numbers, Upstox’s calendar shows. A little further out, the same list points to Lupin, Biocon, Petronet LNG and CRISIL lining up to announce results later in the week.
Brokerages are looking for Titan’s December quarter revenue to jump nearly 29% from a year ago, with profit after tax up roughly 35%, according to figures cited by the Economic Times from five firms’ estimates. Kotak Equities, for its part, sees jewellery margins narrowing by around 90 basis points—0.90 percentage point—blaming a higher mix of gold coin sales and increased marketing spend.
Kalyan Jewellers, which competes publicly with Titan, posted a consolidated net profit surge of 90.36% to 4.16 billion rupees and revenue up 42.11% at 103.43 billion rupees, according to Upstox. Shares shot up as much as 12.26% Monday. Executive director Ramesh Kalyanaraman said, “The current quarter has started off very well despite the volatility in gold prices.” upstox.com
India’s December quarter typically lines up with the festival rush and a slice of the wedding season—prime time for jewellery and discretionary buys. Drugmakers, though, keep an eye on U.S. pricing, track new launches, and watch how fast those one-off windfalls disappear.
A packed calendar isn’t always good news. Heightened expectations put stocks on edge—mid-caps, in particular, can take a beating if margins fall short or guidance turns cautious. One sharp move in a commodity, and the whole quarter looks different.
